A peptide probe for the detection of neurokinin-1 receptor by disaggregation enhanced fluorescence and magnetic resonance signals

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Wu, Jingxian ^a   Zou, Rongfeng ^b   Wang, Qi ^c   Xue, Yajing ^d   Wei, Ping ^d   Yang, Shiping ^e   Wu, Junchen ^a   Tian, He ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NANTONG UNIVERSITY   (China)

^c NANTONG TUMOR HOSPITAL   (China)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^e SHANGHAI NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CONTRAST MEDIUM; GADOLINIUM; NEUROKININ 1 RECEPTOR; PEPTIDE FRAGMENT;

CELL PROLIFERATION; DIAGNOSTIC USE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; LUNG NEOPLASMS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; TUMOR CELL CULTURE;

BIOLOGICAL MARKERS; CELL PROLIFERATION; CONTRAST MEDIA; FLOW CYTOMETRY; FLUORESCENCE; GADOLINIUM; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; PEPTIDE FRAGMENTS; RECEPTORS, NEUROKININ-1; TUMOR CELLS, CULTURED;

EID: 84923341494     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06487     Document Type: Article

References (49)

1. Mayordomo, C. et al. Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2. J. Cell. Physiol. 227, 1358-1366 (2012)
2. Felipe, C. D. et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392, 394-397 (1998)
3. Lucattelli, M., Fineschi, S., Geppetti, P., Gerard, N. P. &Lungarella, G. Neurokinin-1 receptor blockade and murine lung tumorigenesis. Am. J. Respir. Crit. Care Med. 174, 674-683 (2006)
4. Palma, C. Tachykinins and their receptors in human malignancies. Curr. Drug Targets 7, 1043-1052 (2006)
5. Moles, G. et al. Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol. 44, 1127-1133 (2008)
6. Payan, D. G., McGillis, J. P. &Organist, M. L. Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P. J. Biol. Chem. 261, 14321-14329 (1986)
7. Fowler, C. J. &Brännström, G. Substance P enhances forskolin-stimulated cyclic AMP production in human UC11MG astrocytoma cells. Methods Find. Exp. Clin. Pharmacol. 16, 21-28 (1993)
8. Munoz, M. &Covenas, R. Involvement of substance P and the NK-1 receptor in cancer progression. Peptides 48, 1-9 (2013)
9. Yuan, Y., Kwok, R. T. K., Tang, B. Z. &Liu, B. Targeted Theranostic Platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. J. Am. Chem. Soc. 136, 2546-2554 (2014)
10. Frank, R. &Hargreaves, R. Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2, 566-580 (2003)
11. Zeng, X. et al. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. J. Proteome Res. 9, 6440-6449 (2010)
12. Mascaux, C. et al. Early detection and screening of lung cancer. Expert. Rev. Mol. Diagn. 10, 799-815 (2010)
13. Belinsky, S. A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer 4, 707-717 (2004)
14. Spira, A. et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat. Med. 13, 361-366 (2007)
15. Tan, W., Donovan, M. J. &Jiang, J. Aptamers from cell-based selection for bioanalytical applications. Chem. Rev. 113, 2842-2862 (2013)
16. Liang, H. et al. Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy. Acc. Chem. Res. 47, 1891-1901 (2014)
17. Zhu, G. et al. Noncanonical self-Assembly of multifunctional DNA nanoflowers for biomedical applications. J. Am. Chem. Soc. 135, 16438-16445 (2013)
18. Zhao, J., Davidson, M. G., Mahon, M. F., Kociok-Köhn, G. &James, T. D. An enantioselective fluorescent sensor for sugar acids. J. Am. Chem. Soc. 126, 16179-16186 (2004)
19. Wu, J., Zawistowski, A., Ehrmann, M., Yi, T. &Schmuck, C. Peptide functionalized polydiacetylene liposomes act as a fluorescent turn-on sensor for bacterial lipopolysaccharide. J. Am. Chem. Soc. 133, 9720-9723 (2011)
20. Mawn, T.M. et al. In vivo detection of phospholipase C by enzyme-Activated nearinfrared probes. Bioconjugate Chem. 22, 2434-2443 (2011)
21. Ding, D., Li, K., Liu, B. &Tang, B. Z. Bioprobes based on AIE fluorogens. Acc. Chem. Res. 46, 2441-2453 (2013)
22. Alberti, D. et al. A Quantitative relaxometric version of the ELISA test for the measurement of cell surface biomarkers. Angew. Chem., Int. Ed. 53, 3488-3491 (2014)
23. Crich, G. et al. In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes. J. Med. Chem. 49, 4926-4936 (2006)
24. Gao, J. et al. Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. Small 6, 256-261 (2010)
25. Ye, Y. &Chen, X. Integrin targeting for tumor optical imaging. Theranostics 1, 102-126 (2011)
26. Qiu, L. et al. A Targeted, self-delivered, and photocontrolled molecular beacon for mRNA detection in living cells. J. Am. Chem. Soc. 135, 12952-12955 (2013)
27. Sheng, W. et al. Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. Anal. Chem. 84, 4199-4206 (2012)
28. Geninatti Crich, S., Alberti, D., Szabo, I., Aime, S. &Djanashvili, K. MRI visualization of melanoma cells by targeting overexpressed sialic acid with a Gd(III)-dota-en-pba imaging reporter. Angew. Chem. Int. Ed. Engl. 52, 1161-1164 (2013)
29. Sabharanjak, S.&Mayor, S. Folate receptor endocytosis and trafficking. Adv. Drug Delivery. Rev. 56, 1099-1109 (2004)
30. Shaw, S. Y. Molecular imaging in cardiovascular disease: targets and opportunities. Nat. Rev. Cardiol. 6, 569-579 (2009)
31. Zhai, D., Xu, W., Zhang, L. &Chang, Y.-T. The role of 'disaggregation' in optical probe development. Chem. Soc. Rev. 43, 2402-2411 (2014)
32. Maggi, C. A. Themammalian tachykinin receptors. Gen. Pharmacol. 26, 911-944 (1995)
33. Pennefather, J. N. et al. Tachykinins and tachykinin receptors: a growing family. Life Sci. 74, 1445-1463 (2004)
34. Berton, O. &Nestler, E. J. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7, 137-151 (2006)
35. Gröger, G. et al. Switchable supramolecular polymers from the self-Assembly of a small monomer with two orthogonal binding interactions. J. Am. Chem. Soc. 133, 8961-8971 (2011)
36. Yao, Q.-H., Meng, F.-S., Li, F.-Y., Tian, H. &Huang, C.-H. Photoelectric conversion properties of four novel carboxylated hemicyanine dyes on TiO2 electrode. J. Mater. Chem. 13, 1048-1053 (2003)
37. Schildkraut, J. S., Penner, T. L., Willand, C. S. &Ulman, A. Absorption and second-harmonic generation of monomer and aggregate hemicyanine dye in Langmuir-Blodgett films. Opt. Lett. 13, 134-136 (1988)
38. Yuan, W. Z. et al. Changing the behavior of cChromophores from aggregationcaused quenching to aggregation-induced emission: development of highly efficient light emitters in the solid state. Adv. Mater. 22, 2159-2163 (2010)
39. Hofmeier, H., Hoogenboom, R., Wouters, M. E. &Schubert, U. S. High molecular weight supramolecular polymers containing both terpyridine metal complexes and ureidopyrimidinone quadruple hydrogen-bonding units in the main chain. J. Am. Chem. Soc. 127, 2913-2921 (2005)
40. Kawamoto, S. A. et al. Analysis of the interaction of BCL9 with b-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction. Biochemistry 48, 9534-9541 (2009)
41. Zhang, J. et al.Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J. Am. Chem. Soc. 135, 5068-5073 (2013)
42. Yang, L. et al. Engineering Polymeric Aptamers for Selective Cytotoxicity. J. Am. Chem. Soc. 133, 13380-13386 (2011)
43. Lauffer, R. B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 87, 901-927 (1987)
44. Caravan, P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 35, 512 (2006)
45. Bryson, J. M., Reineke, J. W. &Reineke, T. M. Macromolecular imaging agents containing lanthanides: can conceptual promise lead to clinical potential? Macromolecules 45, 8939-8952 (2012)
46. Unger, E. C., Shen, D.-K. &Fritz, T. A. Status of liposomes as MR contrast agents. J. Magn. Reson. Imaging 3, 195-198 (1993)
47. Boros, E., Polasek, M., Zhang, Z. &Caravan, P. Gd (DOTAla): a single amino acid Gd-complex as amodular tool for high relaxivityMRcontrast agent development. J. Am. Chem. Soc. 134, 19858-19868 (2012)
48. Hennig, I. M., Laissue, J. A., Horisberger, U. &Reubi, J.-C. Substance-P receptors in human primary neoplasms: Tumoral and vascular localization. Int. J. Cancer 61, 786-792 (1995)
49. Perez, J. M., Josephson, L., O'Loughlin, T., Högemann, D. &Weissleder, R. Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20, 816-820 (2002)